The primary care nurse practitioner is reviewing a patient's medication list and notices that the patient is on a cannabinoid. The NP knows that the US Food and Drug Administration currently endorses the use of cannabinoids for which of the following conditions?
a. Refractory, spastic, and multiple sclerosis
B. Chronic pain
C. Aids related anorexia and weight loss
D. Chemotherapy induced nausea and vomiting